急性心肌梗死后8周冠状动脉微血管灌注改善与心血管预后改善相关:心肌超声造影的见解
前瞻性队列研究纳入114例成功行PCI的AMI患者,PCI后2-7天以心肌超声造影分为MVP正常(26例)、MVP延迟(50例)和微血管阻塞(38例)三组,比较8周恢复期灌注改善与2年MACE的关系。8周时MVP完全改善者GLS改善更显著(p=0.017)且MACE更少(p=0.044)。
要点
- PCI后2-7天心肌超声造影可区分MVP正常、MVP延迟和微血管阻塞,三组预后相关指标存在差异。
- 8周内MVP完全改善者GLS改善更显著(p=0.017),长期MACE更少(p=0.044)。
- MVP延迟组46.00%和微血管阻塞组13.16%在8周内完全改善,微血管阻塞组55.26%部分改善。
核心结论
- PCI后早期MVP异常的患者中,部分在8周时MVP完全改善;完全改善者心肌功能改善更大且长期MACE风险降低。
研究设计与样本
- 前瞻性队列研究,纳入114例成功行PCI的AMI患者,PCI后2-7天以心肌超声造影行灌注成像分组,基线及8周恢复期比较临床资料、心肌超声造影和心功能,每6个月随访MACE共2年。
关键影像表现/征象
- 心肌超声造影显示MVP延迟组和微血管阻塞组在基线和8周时整体纵向应变(GLS)均低于MVP正常组(p=0.006、p=0.002)。
- MVP延迟组和微血管阻塞组在基线和8周时左心室射血分数(LVEF)均低于MVP正常组(p=0.023、p=0.002)。
- MVP延迟组和微血管阻塞组在基线和8周时心肌灌注评分指数(MPSI)均高于MVP正常组(p<0.001、p<0.001)。
- MVP延迟组和微血管阻塞组在基线和8周时室壁运动异常节段数均多于MVP正常组(p<0.001、p<0.001)。
诊断标准与关键数值
- PCI后2-7天以心肌超声造影灌注成像将患者分为MVP正常组26例(22.8%)、MVP延迟组50例(43.9%)和微血管阻塞组38例(33.4%)。
- 8周内MVP完全改善:MVP延迟组23/50例(46.00%),微血管阻塞组5/38例(13.16%)。
- 8周内MVP部分改善:微血管阻塞组21/38例(55.26%)。
- MVP完全改善者较部分或无改善者GLS改善更显著(p=0.017)且MACE更少(p=0.044)。
临床应用与阅片要点
- PCI后2-7天可用心肌超声造影评估MVP并分为MVP正常、MVP延迟和微血管阻塞,作为早期风险分层依据。
- 8周恢复期复查心肌超声造影可识别MVP完全改善者,该类患者心肌功能改善更大且长期MACE更少。
- 原文结论未据此给出具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Coronary microcirculation dysfunction (CMD) after acute myocardial infarction (AMI) significantly affects cardiovascular prognosis. However, the influence of an improvement in microvascular perfusion (MVP) during the recovery period from AMI on the long-term prognosis remains unclear. This study aims to assess the improvement in MVP during the healing process after percutaneous coronary intervention (post-PCI) for AMI using myocardial contrast echocardiography (MCE), and to investigate its correlation with major adverse cardiovascular events (MACE).
METHODS: A prospective cohort study was conducted to evaluate a total of 114 AMI patients successfully treated with percutaneous coronary intervention (PCI). Patients were classified as having normal MVP (nMVP), delayed MVP (dMVP) or microvascular obstruction (MVO) based on perfusion imaging by MCE between 2 and 7 d post-PCI. Clinical data, MCE and cardiac function at baseline (2-7 d post-PCI) and after 8 wk of recovery were compared among the three groups. MACE was followed up every 6 mo over a 2-y period.
RESULTS: As detected by MCE, there were 26 (22.8%), 50 (43.9%) and 38 (33.4%) AMI patients in the nMVP group, dMVP group and MVO group, respectively. AMI patients with dMVP and MVO suffered from significantly lower global longitudinal strain (GLS, p = 0.006, p = 0.002), lower left ventricular ejection fraction (LVEF, p = 0.023, p = 0.002), higher myocardial perfusion score index (MPSI, p < 0.001, p < 0.001) and more segments of wall motion abnormalities (WMA, p < 0.001, p < 0.001) than nMVP at both baseline and 8 wk. 23/50 (46.00%) patients in the dMVP group and 5/38 (13.16%) patients in the MVO group achieved complete improvement, while 21/38 (55.26%) patients in the MVO group achieved partial improvement in MVP within 8 wk. AMI patients with complete improvement had exhibited significantly greater improvements in GLS (p = 0.017), and experienced fewer MACE (p = 0.044) compared to those with partial or no improvement.
CONCLUSION: Among patients exhibiting abnormal MVP in the early phase following PCI for AMI, a subset demonstrated complete improvement of MVP at 8 wk. Patients with complete MVP improvement showed greater enhancement in myocardial function and a reduced risk of long-term MACE.
引用
- Zhan W, Lu M, Zhao X, et al. Improved Coronary Microvascular Perfusion 8 Weeks After Acute Myocardial Infarction Is Associated with Improved Cardiovascular Prognosis: Insights from Myocardial Contrast Echocardiography. Ultrasound Med Biol. 2025. PMID: 41436343. doi:10.1016/j.ultrasmedbio.2025.10.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。